Stereotaxis Statistics
Total Valuation
Stereotaxis has a market cap or net worth of $199.11 million. The enterprise value is $194.59 million.
Important Dates
The last earnings date was Monday, November 11, 2024, after market close.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Stereotaxis has 84.73 million shares outstanding. The number of shares has increased by 6.39% in one year.
| Current Share Class | 84.73M |
| Shares Outstanding | 84.73M |
| Shares Change (YoY) | +6.39% |
| Shares Change (QoQ) | +1.48% |
| Owned by Insiders (%) | 11.74% |
| Owned by Institutions (%) | 31.55% |
| Float | 58.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.87 |
| Forward PS | 5.88 |
| PB Ratio | 18.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.39 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.46% and return on invested capital (ROIC) is -51.15%.
| Return on Equity (ROE) | -106.46% |
| Return on Assets (ROA) | -27.99% |
| Return on Capital (ROIC) | -51.15% |
| Revenue Per Employee | $206,090 |
| Profits Per Employee | -$187,648 |
| Employee Count | 122 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.50% in the last 52 weeks. The beta is 1.55, so Stereotaxis's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | +37.50% |
| 50-Day Moving Average | 2.08 |
| 200-Day Moving Average | 2.14 |
| Relative Strength Index (RSI) | 57.06 |
| Average Volume (20 Days) | 457,116 |
Short Selling Information
The latest short interest is 2.54 million, so 3.00% of the outstanding shares have been sold short.
| Short Interest | 2.54M |
| Short Previous Month | 3.29M |
| Short % of Shares Out | 3.00% |
| Short % of Float | 4.38% |
| Short Ratio (days to cover) | 6.26 |
Income Statement
In the last 12 months, Stereotaxis had revenue of $25.14 million and -$22.89 million in losses. Loss per share was -$0.27.
| Revenue | 25.14M |
| Gross Profit | 14.12M |
| Operating Income | -21.38M |
| Pretax Income | -19.87M |
| Net Income | -22.89M |
| EBITDA | -20.63M |
| EBIT | -21.38M |
| Loss Per Share | -$0.27 |
Full Income StatementBalance Sheet
The company has $10.66 million in cash and $6.14 million in debt, giving a net cash position of $4.53 million or $0.05 per share.
| Cash & Cash Equivalents | 10.66M |
| Total Debt | 6.14M |
| Net Cash | 4.53M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 16.22M |
| Book Value Per Share | 0.13 |
| Working Capital | 8.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$12.20 million and capital expenditures -$32,000, giving a free cash flow of -$12.23 million.
| Operating Cash Flow | -12.20M |
| Capital Expenditures | -32,000 |
| Free Cash Flow | -12.23M |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
Gross margin is 56.14%, with operating and profit margins of -85.02% and -85.79%.
| Gross Margin | 56.14% |
| Operating Margin | -85.02% |
| Pretax Margin | -85.79% |
| Profit Margin | -85.79% |
| EBITDA Margin | -82.06% |
| EBIT Margin | -85.02% |
| FCF Margin | n/a |
Dividends & Yields
Stereotaxis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.39% |
| Shareholder Yield | -6.39% |
| Earnings Yield | -11.50% |
| FCF Yield | -6.14% |
Analyst Forecast
The average price target for Stereotaxis is $4.50, which is 94.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 94.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 11, 2012. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jul 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
Stereotaxis has an Altman Z-Score of -13.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.09 |
| Piotroski F-Score | 2 |